Amoscanate (500 mg/kg; p.o.; 10 days) destructs ependyma and periventricular brain[1]. Amoscanate (250 and 500 mg/kg; p.o.; 28 days) elicits necrosis, Ca++-positive microgranules, pyknosis and edema localized in ependyma/subependyma in the medial striatum[1]. Amoscanate (25~500 mg/kg; p.o.; 20 days) elicits progressive necrosis of ependyma[1]. Amoscanate elicits massive ultrastructural damage in ependymal cells[1]. Animal Model: Sprague-Dawley rats[1] Dosage: 500 mg/kg Administration: P.o.; 10 days Result: Destructed ependyma and periventricular brain. Animal Model: Sprague-Dawley rats[1] Dosage: 250 and 500 mg/kg Administration: P.o.; 28 days Result: Elicited necrosis, Ca++-positive microgranules, pyknosis and edema localized in ependyma/subependyma in the medial striatum. Animal Model: Sprague-Dawley rats[1] Dosage: 25~500 mg/kg Administration: P.o.; 20 days Result: Elicited progressive necrosis of ependymal.
In Vitro
Kinase Assay
Cell Assay
Animal Administration
References
[1]. Johanson C, et al. The distributional nexus of choroid plexus to cerebrospinal fluid, ependyma and brain: toxicologic/pathologic phenomena, periventricular destabilization, and lesion spread. Toxicol Pathol. 2011;39(1):186-212.
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
